Related Experiment Videos
Treatment of depression
1Westfälisches Zentrum für Psychiatrie der Ruhr-Universität, Bochum, Germany.
Journal of Geriatric Psychiatry and Neurology
|October 1, 1994
Summary
Depression treatments have evolved from ancient plant extracts and therapies to modern pharmacotherapy. Current antidepressant drug development focuses on improving patient tolerance and therapeutic outcomes.
Area of Science:
- Psychiatry
- Pharmacology
- Ethnobotany
Background:
- Depression is a prevalent psychiatric disorder with a long history of treatment approaches.
- Traditional medicine utilized various plant extracts and psychotherapeutic interventions for mood disorders.
Observation:
- Historical treatments included opium, belladonna, hashish, hyoscyamine, scopolamine, and hypericum oil.
- 19th-century pharmacotherapy saw the introduction of bromides, codeine, chloral hydrate, paraldehyde, and barbiturates.
- Modern antidepressant therapy began with imipramine in 1957, leading to approximately 40 marketed drugs.
Findings:
- The evolution of depression treatment spans millennia, from ethnobotanical remedies to synthetic pharmaceuticals.
- Significant advancements in pharmacotherapy occurred in the 19th and 20th centuries.
Implications:
- Future antidepressant drug development should prioritize enhanced patient tolerance.
- Understanding historical treatments provides context for contemporary psychiatric pharmacotherapy.